Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Organon & Co
OGN
$3.56B
| $33.5M | 0.02% |
2,320,619
-1,255,657
| -35% | -$17.1M |
|
452
Equity Lifestyle Properties
ELS
$13.1B
| $33.3M | 0.02% |
472,767
-232,006
| -33% | -$15.8M |
|
453
Walmart Inc
WMT
$909B
| $33.2M | 0.02% |
631,773
+35,787
| +6% | +$1.89M |
|
454
Embecta
EMBC
$218M
| $33.1M | 0.02% |
1,746,137
+66,429
| +4% | +$1.09M |
|
455
Sanofi
SNY
$107B
| $32.8M | 0.02% |
660,198
-116,812
| -15% | -$5.71M |
|
|
CWAN
456
DELISTED
Clearwater Analytics
CWAN
| $32.7M | 0.02% |
1,633,265
+20,186
| +1% | +$398K |
|
457
Baker Hughes
BKR
$58.3B
| $32.6M | 0.02% |
953,598
-297,483
| -24% | -$10.1M |
|
458
Pinterest
PINS
$13.7B
| $32.2M | 0.02% |
870,316
+813,868
| +1,442% | +$25.6M |
|
459
Travelers Companies
TRV
$81.1B
| $32.2M | 0.02% |
168,889
+30,375
| +22% | +$5.26M |
|
460
OFG Bancorp
OFG
$2.21B
| $31.9M | 0.02% |
851,910
+239,117
| +39% | +$7.87M |
|
461
Napco Security Technologies
NSSC
$1.3B
| $31.9M | 0.02% |
931,677
+22,322
| +2% | +$592K |
|
462
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $31.7M | 0.02% |
389,814
+355,180
| +1,026% | +$27.4M |
|
463
Suncor Energy
SU
$77.7B
| $31.6M | 0.02% |
982,154
-77,737
| -7% | -$2.54M |
|
464
Gibraltar Industries
ROCK
$1.28B
| $31.4M | 0.02% |
398,183
-24
| -0% | -$1.64K |
|
465
Lexeo Therapeutics
LXEO
$338M
| $31.3M | 0.02% |
+2,330,738
| New | +$29M |
|
466
Janus Henderson Securitized Income ETF
JSI
$1.52B
| $30.9M | 0.02% |
+602,333
| New | +$30.6M |
|
467
Wolfspeed
WOLF
$1.04B
| $30.8M | 0.02% |
706,954
+235,634
| +50% | +$8.55M |
|
|
AVDX
468
DELISTED
AvidXchange
AVDX
| $30.5M | 0.02% |
2,463,633
+330,272
| +15% | +$3.3M |
|
|
DOC
469
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $30.4M | 0.02% |
2,287,460
-688,309
| -23% | -$8.18M |
|
470
AutoZone
AZO
$51.3B
| $30.3M | 0.02% |
11,730
-1,804
| -13% | -$4.68M |
|
|
HEES
471
DELISTED
H&E Equipment Services
HEES
| $30.2M | 0.02% |
577,876
-99,102
| -15% | -$4.48M |
|
472
Vesta Real Estate
VTMX
$3.22B
| $30.2M | 0.02% |
+762,194
| New | +$26.7M |
|
473
Popular Inc
BPOP
$11B
| $29.9M | 0.02% |
364,740
+61,192
| +20% | +$4.33M |
|
|
K
474
DELISTED
Kellanova
K
| $29.2M | 0.02% |
522,322
+8,297
| +2% | +$434K |
|
475
AAR Corp
AIR
$5.4B
| $29.1M | 0.02% |
466,408
+20,025
| +4% | +$1.29M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.